A Platform Study Based on Specific Tracer for Evaluating the Therapeutic Efficacy of Systemic Treatment for Breast Cancer Using PET/MRI

NCT07419867 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DIAGNOSTIC_TEST: Chemotherapy plus dual-target therapy
DIAGNOSTIC_TEST: Treatment including HER2 ADC
DIAGNOSTIC_TEST: Treatment including immunotherapy
DIAGNOSTIC_TEST: Treatment including Nectin-4 ADC
DIAGNOSTIC_TEST: Treatment including Trop-2 ADC
DIAGNOSTIC_TEST: Treatment including CDK4/6 inhibitor

Sponsor

Fudan University